Keita Sakurai1, Daita Kaneda2, Satoru Morimoto3, Yuto Uchida4, Shohei Inui5, Yasuyuki Kimura6, Takashi Kato1, Kengo Ito1, Yoshio Hashizume2. 1. Department of Radiology National Center for Geriatrics and Gerontology Obu Japan. 2. Choju Medical Institute, Fukushimura Hospital Toyohashi Japan. 3. Department of Physiology School of Medicine, Keio University Tokyo Japan. 4. Department of Neurology Nagoya City University Graduate School of Medical Sciences Nagoya Japan. 5. Department of Radiology Graduate School of Medicine, The University of Tokyo Tokyo Japan. 6. Department of Clinical and Experimental Neuroimaging National Center for Geriatrics and Gerontology Obu Japan.
Abstract
Background: Contrary to pure cases, the influence of comorbid argyrophilic grain disease (AGD) in progressive supranuclear palsy (PSP) has not been sufficiently evaluated. Objectives: We compared the clinicoradiological features of 12 patients with PSP with (PSPw/AG) and 8 patients without AGD (PSPw/oAG). Methods: Medical records and magnetic resonance imaging were checked retrospectively from a single brain bank database. Results: Other than AGD, no differences were observed in any other neurodegenerative pathologies between the 2 groups. Ages at onset and deaths of patients with PSPw/AG were higher than those of patients with PSPw/oAG (77.9 ± 4.9 vs. 68.9 ± 5.9, and 87.0 ± 5.7 vs. 78.1 ± 5.0; P = 0.003 and P = 0.002, respectively). In addition to the later onset of motor symptoms, initial amnestic presentations were limited to 5 patients with PSPw/AG. Both characteristic midbrain atrophy and severe ambient gyrus atrophy were detected exclusively in 8 patients with PSPw/AG. Conclusions: Initial amnestic presentations and ambient gyrus atrophy may be characteristic of PSPw/AG.
Background: Contrary to pure cases, the influence of comorbid argyrophilic grain disease (AGD) in progressive supranuclear palsy (PSP) has not been sufficiently evaluated. Objectives: We compared the clinicoradiological features of 12 patients with PSP with (PSPw/AG) and 8 patients without AGD (PSPw/oAG). Methods: Medical records and magnetic resonance imaging were checked retrospectively from a single brain bank database. Results: Other than AGD, no differences were observed in any other neurodegenerative pathologies between the 2 groups. Ages at onset and deaths of patients with PSPw/AG were higher than those of patients with PSPw/oAG (77.9 ± 4.9 vs. 68.9 ± 5.9, and 87.0 ± 5.7 vs. 78.1 ± 5.0; P = 0.003 and P = 0.002, respectively). In addition to the later onset of motor symptoms, initial amnestic presentations were limited to 5 patients with PSPw/AG. Both characteristic midbrain atrophy and severe ambient gyrus atrophy were detected exclusively in 8 patients with PSPw/AG. Conclusions: Initial amnestic presentations and ambient gyrus atrophy may be characteristic of PSPw/AG.